Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

TNF-alpha and IL-4 regulate expression of IL-13 receptor alpha2 on human fibroblasts.

Yoshikawa M, Nakajima T, Tsukidate T, Matsumoto K, Iida M, Otori N, Haruna S, Moriyama H, Saito H.

Biochem Biophys Res Commun. 2003 Dec 26;312(4):1248-55.

PMID:
14652008
2.

Impact of interleukin-13 responsiveness on the synthetic and proliferative properties of Th1- and Th2-type pulmonary granuloma fibroblasts.

Jakubzick C, Choi ES, Kunkel SL, Joshi BH, Puri RK, Hogaboam CM.

Am J Pathol. 2003 May;162(5):1475-86.

3.

Cytokine regulation of IL-13Ralpha2 and IL-13Ralpha1 in vivo and in vitro.

Zheng T, Zhu Z, Liu W, Lee CG, Chen Q, Homer RJ, Elias JA.

J Allergy Clin Immunol. 2003 Apr;111(4):720-8.

PMID:
12704349
4.

Re-evaluation of fibrogenic cytokines in lung fibrosis.

Kelly M, Kolb M, Bonniaud P, Gauldie J.

Curr Pharm Des. 2003;9(1):39-49. Review.

PMID:
12570673
5.

Effects of Th2 cytokines on expression of collagen, MMP-1, and TIMP-1 in conjunctival fibroblasts.

Leonardi A, Cortivo R, Fregona I, Plebani M, Secchi AG, Abatangelo G.

Invest Ophthalmol Vis Sci. 2003 Jan;44(1):183-9.

PMID:
12506073
7.

Idiopathic pulmonary fibrosis: new insights in its pathogenesis.

Pardo A, Selman M.

Int J Biochem Cell Biol. 2002 Dec;34(12):1534-8. Review.

PMID:
12379275
9.

Apoptotic pathways of cell death induced by an interleukin-13 receptor-targeted recombinant cytotoxin in head and neck cancer cells.

Kawakami M, Kawakami K, Puri RK.

Cancer Immunol Immunother. 2002 Feb;50(12):691-700. Epub 2001 Dec 7.

PMID:
11862421
10.

IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.

Rahaman SO, Sharma P, Harbor PC, Aman MJ, Vogelbaum MA, Haque SJ.

Cancer Res. 2002 Feb 15;62(4):1103-9.

11.

Growth factors in idiopathic pulmonary fibrosis: relative roles.

Allen JT, Spiteri MA.

Respir Res. 2002;3:13. Epub 2001 Nov 28. Review.

14.

Histopathologic variability in usual and nonspecific interstitial pneumonias.

Flaherty KR, Travis WD, Colby TV, Toews GB, Kazerooni EA, Gross BH, Jain A, Strawderman RL, Flint A, Lynch JP, Martinez FJ.

Am J Respir Crit Care Med. 2001 Nov 1;164(9):1722-7.

PMID:
11719316
15.

IL-13 fusion cytotoxin ameliorates chronic fungal-induced allergic airway disease in mice.

Blease K, Jakubzick C, Schuh JM, Joshi BH, Puri RK, Hogaboam CM.

J Immunol. 2001 Dec 1;167(11):6583-92.

16.

Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality.

King TE Jr, Schwarz MI, Brown K, Tooze JA, Colby TV, Waldron JA Jr, Flint A, Thurlbeck W, Cherniack RM.

Am J Respir Crit Care Med. 2001 Sep 15;164(6):1025-32.

PMID:
11587991
17.

IL-4 and IL-13 induce myofibroblastic phenotype of human lung fibroblasts through c-Jun NH2-terminal kinase-dependent pathway.

Hashimoto S, Gon Y, Takeshita I, Maruoka S, Horie T.

J Allergy Clin Immunol. 2001 Jun;107(6):1001-8.

PMID:
11398077
18.

Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression.

Ramos C, Montaño M, García-Alvarez J, Ruiz V, Uhal BD, Selman M, Pardo A.

Am J Respir Cell Mol Biol. 2001 May;24(5):591-8.

PMID:
11350829
20.

Unusual interleukin-4 and -13 signaling in human normal and tumor lung fibroblasts.

Doucet C, Jasmin C, Azzarone B.

Oncogene. 2000 Nov 30;19(51):5898-905.

PMID:
11127821
Items per page

Supplemental Content

Write to the Help Desk